-
May 19, 2025, 5:30 pm474 ptsHotTop
Slashdot
Regeneron Pharmaceuticals is acquiring most of 23andMe's assets for $256 million. The sale includes 23andMe's Personal Genome Service, Total Health and Research Services business lines. What's not included is 23andMe's telehealth unit, Lemonaid Health, which the company acquired for around $400 million in 2021.…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.


















